Another possible explanation is that the death receptor pathway and its regulation by FLIPL is important for certain MYC-induced tumors, such as Eμ-myc driven B cell lymphoma, but less important in the case of AML. Here, MYC is linked to B-cell non-Hodgkin lymphoma.